SpringerLink
Log in

Coronary Venous Bypass Lesions

  • Chapter
  • First Online:
Textbook of Catheter-Based Cardiovascular Interventions

  • 448 Accesses

Abstract

Saphenous vein graft (SVG) percutaneous coronary interventions (PCIs) are common, currently representing approximately 6% of the overall PCI volume. SVG PCI is associated with higher risk of periprocedural complications and lower long-term patency compared with native coronary artery PCI; hence, the latter is preferred to SVG PCI whenever possible. Embolic protection devices and intragraft vasodilator administration can help to reduce the risk or consequences of distal embolization; however, they are currently underutilized. Drug-eluting stents can reduce the risk of in-stent restenosis and the need for repeat revascularization as compared with bare-metal stents in SVG lesions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
EUR 29.95
Price includes VAT (Spain)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
EUR 149.79
Price includes VAT (Spain)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
EUR 187.19
Price includes VAT (Spain)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info
Hardcover Book
EUR 259.99
Price includes VAT (Spain)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Alexander JH, Hafley G, Harrington RA, Peterson ED, Ferguson TB Jr, Lorenz TJ, Goyal A, Gibson M, Mack MJ, Gennevois D, Califf RM, Kouchoukos NT. Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial. JAMA. 2005;294(19):2446–54.

    Article  PubMed  Google Scholar 

  2. Shroyer AL, Grover FL, Hattler B, Collins JF, McDonald GO, Kozora E, Lucke JC, Baltz JH, Novitzky D, The Veterans Affairs Randomized On/Off Bypass Study Group. On-pump versus off-pump coronary-artery bypass surgery. N Engl J Med. 2009;361(19):1827–37.

    Article  CAS  PubMed  Google Scholar 

  3. Goldman S, Zadina K, Moritz T, Ovitt T, Sethi G, Copeland JG, Thottapurathu L, Krasnicka B, Ellis N, Anderson RJ, Henderson W. Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery results from a Department of Veterans Affairs Cooperative Study. J Am Coll Cardiol. 2004;44(11):2149–56.

    Article  PubMed  Google Scholar 

  4. Fitzgibbon GM, Kafka HP, Leach AJ, Keon WJ, Hooper GD, Burton JR. Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. J Am Coll Cardiol. 1996;28(3):616–26.

    Article  CAS  PubMed  Google Scholar 

  5. Yahagi K, Kolodgie FD, Otsuka F, Finn AV, Davis HR, Joner M, Virmani R. Pathophysiology of native coronary, vein graft, and in-stent atherosclerosis. Nat Rev Cardiol. 2016;13(2):79–98.

    Article  CAS  PubMed  Google Scholar 

  6. Morrison DA, Sethi G, Sacks J, Henderson WG, Grover F, Sedlis S, Esposito R, Investigators of the Department of Veterans Affairs Cooperative Study AWESOME. Percutaneous coronary intervention versus repeat bypass surgery for patients with medically refractory myocardial ischemia: AWESOME randomized trial and registry experience with post-CABG patients. J Am Coll Cardiol. 2002;40(11):1951–4.

    Article  PubMed  Google Scholar 

  7. Brilakis ES, Lee M, Mehilli J, Marmagkiolis K, Rodes-Cabau J, Sachdeva R, Kotsia A, Christopoulos G, Rangan BV, Mohammed A, Banerjee S. Saphenous vein graft interventions. Curr Treat Options Cardiovasc Med. 2014;16(5):301.

    Article  PubMed  Google Scholar 

  8. Brilakis ES, Wang TY, Rao SV, Banerjee S, Goldman S, Shunk K, Kar B, Holmes DR Jr, Dai D, Chin CT, Harding TM, Roe MT. Frequency and predictors of drug-eluting stent use in saphenous vein bypass graft percutaneous coronary interventions: a report from the American College of Cardiology National Cardiovascular Data CathPCI registry. JACC Cardiovasc Interv. 2010;3(10):1068–73.

    Article  PubMed  Google Scholar 

  9. Banerjee S, Brilakis ES. Embolic protection during saphenous vein graft interventions. J Invasive Cardiol. 2009;21(8):415–7.

    PubMed  Google Scholar 

  10. Keeley EC, Velez CA, O'Neill WW, Safian RD. Long-term clinical outcome and predictors of major adverse cardiac events after percutaneous interventions on saphenous vein grafts. J Am Coll Cardiol. 2001;38(3):659–65.

    Article  CAS  PubMed  Google Scholar 

  11. Brennan JM, Sketch MH Jr, Dai D, Trilesskaya M, Al-Hejily W, Rao SV, Brilakis E, Messenger JC, Shaw RE, Anstrom KJ, Peterson ED, Douglas PS. Safety and clinical effectiveness of drug-eluting stents for saphenous vein graft intervention in older individuals: results from the medicare-linked National Cardiovascular Data Registry((R)) CathPCI registry((R)) (2005-2009). Catheter Cardiovasc Interv. 2016;87(1):43–9.

    Article  PubMed  Google Scholar 

  12. Varghese I, Boatman DM, Peters CT, Daye J, Haider A, Roesle M, Banerjee S, Brilakis ES. Impact on contrast, fluoroscopy, and catheter utilization from knowing the coronary artery bypass graft anatomy before diagnostic coronary angiography. Am J Cardiol. 2008;101(12):1729–32.

    Article  PubMed  Google Scholar 

  13. Eisenhauer MD, Malik JA, Coyle LC, Arendt MA. Impact of aorto-coronary graft markers on subsequent graft patency: a retrospective review. Catheter Cardiovasc Diagn. 1997;42(3):259–61.

    Article  CAS  Google Scholar 

  14. Dimas B, Lindsey JB, Banerjee S, Brilakis ES. ST-segment elevation acute myocardial infarction due to severe hypotension and proximal left subclavian artery stenosis in a prior coronary artery bypass graft patient. Cardiovasc Revasc Med. 2009;10(3):191–4.

    Article  PubMed  Google Scholar 

  15. Rigattieri S, Sciahbasi A, Brilakis ES, Burzotta F, Rathore S, Pugliese FR, Fedele S, Ziakas AG, Zhou YJ, Guzman LA, Anderson RA. Meta-analysis of radial versus femoral artery approach for coronary procedures in patients with previous coronary artery bypass grafting. Am J Cardiol. 2016;117(8):1248–55.

    Article  PubMed  Google Scholar 

  16. Michael TT, Alomar M, Papayannis A, Mogabgab O, Patel VG, Rangan BV, Luna M, Hastings JL, Grodin J, Abdullah S, Banerjee S, Brilakis ES. A randomized comparison of the transradial and transfemoral approaches for coronary artery bypass graft angiography and intervention: the RADIAL-CABG trial (RADIAL versus femoral access for coronary artery bypass graft angiography and intervention). JACC Cardiovasc Interv. 2013;6(11):1138–44.

    Article  PubMed  Google Scholar 

  17. Cooper L, Banerjee S, Brilakis ES. Crossover from radial to femoral access during a challenging percutaneous coronary intervention can make the difference between success and failure. Cardiovasc Revasc Med. 2010;11(4):266 e5–8.

    Article  Google Scholar 

  18. Wiper A, Mamas M, El-Omar M. Use of the GuideLiner catheter in facilitating coronary and graft intervention. Cardiovasc Revasc Med. 2011;12(1):68 e5–7.

    Article  Google Scholar 

  19. Baim DS, Wahr D, George B, Leon MB, Greenberg J, Cutlip DE, Kaya U, Popma JJ, Ho KK, Kuntz RE. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation. 2002;105(11):1285–90.

    PubMed  Google Scholar 

  20. Stone GW, Rogers C, Hermiller J, Feldman R, Hall P, Haber R, Masud A, Cambier P, Caputo RP, Turco M, Kovach R, Brodie B, Herrmann HC, Kuntz RE, Popma JJ, Ramee S, Cox DA. Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass grafts. Circulation. 2003;108(5):548–53.

    Article  PubMed  Google Scholar 

  21. Carrozza JP Jr, Mumma M, Breall JA, Fernandez A, Heyman E, Metzger C. Randomized evaluation of the TriActiv balloon-protection flush and extraction system for the treatment of saphenous vein graft disease. J Am Coll Cardiol. 2005;46(9):1677–83.

    Article  PubMed  Google Scholar 

  22. Holmes DR, Coolong A, O'Shaughnessy C, Chauhan M, Van Langenhove G, Hall P, Vermeersch P, Verlee P, Popma JJ, Cutlip D, Kuntz RE. Comparison of the CardioShield filter with the guardwire balloon in the prevention of embolisation during vein graft intervention: results from the CAPTIVE randomised trial. EuroIntervention. 2006;2(2):161–8.

    PubMed  Google Scholar 

  23. Mauri L, Cox D, Hermiller J, Massaro J, Wahr J, Tay SW, Jonas M, Popma JJ, Pavliska J, Wahr D, Rogers C. The PROXIMAL trial: proximal protection during saphenous vein graft intervention using the Proxis embolic protection system: a randomized, prospective, multicenter clinical trial. J Am Coll Cardiol. 2007;50(15):1442–9.

    Article  PubMed  Google Scholar 

  24. Kereiakes DJ, Turco MA, Breall J, Farhat NZ, Feldman RL, McLaurin B, Popma JJ, Mauri L, Zimetbaum P, Massaro J, Cutlip DE. A novel filter-based distal embolic protection device for percutaneous intervention of saphenous vein graft lesions: results of the AMEthyst randomized controlled trial. JACC Cardiovasc Interv. 2008;1(3):248–57.

    Article  PubMed  Google Scholar 

  25. Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Nallamothu BK, Ting HH. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention. A report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol. 2011;58(24):e44–122.

    Article  PubMed  Google Scholar 

  26. Brennan JM, Al-Hejily W, Dai D, Shaw RE, Trilesskaya M, Rao SV, Brilakis ES, Anstrom KJ, Messenger JC, Peterson ED, Douglas PS, Sketch MH Jr. Three-year outcomes associated with embolic protection in saphenous vein graft intervention: results in 49 325 senior patients in the Medicare-linked National Cardiovascular Data Registry CathPCI Registry. Circ Cardiovasc Interv. 2015;8(3):e001403.

    Article  PubMed  Google Scholar 

  27. Abdel-Karim AR, Papayannis AC, Mahmood A, Michael TT, Rangan BV, Makke L, Banerjee S, Brilakis ES. Role of embolic protection devices in ostial saphenous vein graft lesions. Catheter Cardiovasc Interv. 2012;80(7):1120–6.

    Article  PubMed  Google Scholar 

  28. Savage MP, Douglas JS Jr, Fischman DL, Pepine CJ, King SB 3rd, Werner JA, Bailey SR, Overlie PA, Fenton SH, Brinker JA, Leon MB, Goldberg S. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. Saphenous Vein De Novo Trial Investigators. N Engl J Med. 1997;337(11):740–7.

    Article  CAS  PubMed  Google Scholar 

  29. Hanekamp CE, Koolen JJ, Den Heijer P, Schalij MJ, Piek JJ, Bar FW, De Scheerder I, Bonnier HJ, Pijls NH. Randomized study to compare balloon angioplasty and elective stent implantation in venous bypass grafts: the Venestent study. Catheter Cardiovasc Interv. 2003;60(4):452–7.

    Article  PubMed  Google Scholar 

  30. Schachinger V, Hamm CW, Munzel T, Haude M, Baldus S, Grube E, Bonzel T, Konorza T, Koster R, Arnold R, Haase J, Probst P, vom Dahl J, Neumann FJ, Mudra H, Hennen B, Thiele L, Zeiher AM. A randomized trial of polytetrafluoroethylene-membrane-covered stents compared with conventional stents in aortocoronary saphenous vein grafts. J Am Coll Cardiol. 2003;42(8):1360–9.

    Article  CAS  PubMed  Google Scholar 

  31. Stankovic G, Colombo A, Presbitero P, van den Branden F, Inglese L, Cernigliaro C, Niccoli L, Bartorelli AL, Rubartelli P, Reifart N, Heyndrickx GR, Saunamaki K, Morice MC, Sgura FA, Di Mario C. Randomized evaluation of polytetrafluoroethylene-covered stent in saphenous vein grafts: the randomized evaluation of polytetrafluoroethylene COVERed stent in Saphenous vein grafts (RECOVERS) trial. Circulation. 2003;108(1):37–42.

    Article  CAS  PubMed  Google Scholar 

  32. Vermeersch P, Agostoni P, Verheye S, Van den Heuvel P, Convens C, Bruining N, Van den Branden F, Van Langenhove G. Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC Trial. J Am Coll Cardiol. 2006;48(12):2423–31.

    Article  CAS  PubMed  Google Scholar 

  33. Abizaid A, Weiner B, Bailey SR, Londero H. Use of a self-expanding super-elastic all-metal endoprosthesis; to treat degenerated SVG lesions: the SESAME first in man trial. Catheter Cardiovasc Interv. 2010;76(6):781–6.

    Article  PubMed  Google Scholar 

  34. Vermeersch P, Agostoni P, Verheye S, Van den Heuvel P, Convens C, Van den Branden F, Van Langenhove G. Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: results from the randomized DELAYED RRISC trial. J Am Coll Cardiol. 2007;50(3):261–7.

    Article  CAS  PubMed  Google Scholar 

  35. Brilakis ES, Lichtenwalter C, Abdel-karim AR, de Lemos JA, Obel O, Addo T, Roesle M, Haagen D, Rangan BV, Saeed B, Bissett JK, Sachdeva R, Voudris VV, Karyofillis P, Kar B, Rossen J, Fasseas P, Berger P, Banerjee S. Continued benefit from paclitaxel-eluting compared with bare-metal stent implantation in saphenous vein graft lesions during long-term follow-up of the SOS (Stenting of Saphenous Vein Grafts) trial. JACC Cardiovasc Interv. 2011;4(2):176–82.

    Article  PubMed  Google Scholar 

  36. Mehilli J, Pache J, Abdel-Wahab M, Schulz S, Byrne RA, Tiroch K, Hausleiter J, Seyfarth M, Ott I, Ibrahim T, Fusaro M, Laugwitz KL, Massberg S, Neumann FJ, Richardt G, Schomig A, Kastrati A. Drug-eluting versus bare-metal stents in saphenous vein graft lesions (ISAR-CABG): a randomised controlled superiority trial. Lancet. 2011;378(9796):1071–8.

    Article  CAS  PubMed  Google Scholar 

  37. Stone GW, Goldberg S, O'Shaughnessy C, Midei M, Siegel RM, Cristea E, Dangas G, Lansky AJ, Mehran R. 5-year follow-up of polytetrafluoroethylene-covered stents compared with bare-metal stents in aortocoronary saphenous vein grafts the randomized BARRICADE (barrier approach to restenosis: restrict intima to curtail adverse events) trial. JACC Cardiovasc Interv. 2011;4(3):300–9.

    Article  PubMed  Google Scholar 

  38. Turco MA, Buchbinder M, Popma JJ, Weissman NJ, Mann T, Doucet S, Johnson WL Jr, Greenberg JD, Leadley K, Russell ME. Pivotal, randomized U.S. study of the Symbiottrade mark covered stent system in patients with saphenous vein graft disease: eight-month angiographic and clinical results from the Symbiot III trial. Catheter Cardiovasc Interv. 2006;68(3):379–88.

    Article  PubMed  Google Scholar 

  39. Brilakis ES, Lichtenwalter C, de Lemos JA, Roesle M, Obel O, Haagen D, Saeed B, Gadiparthi C, Bissett JK, Sachdeva R, Voudris VV, Karyofillis P, Kar B, Rossen J, Fasseas P, Berger P, Banerjee S. A randomized controlled trial of a paclitaxel-eluting stent versus a similar bare-metal stent in saphenous vein graft lesions the SOS (Stenting of Saphenous Vein Grafts) trial. J Am Coll Cardiol. 2009;53(11):919–28.

    Article  CAS  PubMed  Google Scholar 

  40. Hong YJ, Pichard AD, Mintz GS, Kim SW, Lee SY, Kim SY, Ahn Y, Jeong MH, Satler LF, Kent KM, Suddath WO, Weissman NJ, Kang JC, Waksman R. Outcome of undersized drug-eluting stents for percutaneous coronary intervention of saphenous vein graft lesions. Am J Cardiol. 2010;105(2):179–85.

    Article  CAS  PubMed  Google Scholar 

  41. Gracida M, Romaguera R, Jacobi F, Gomez-Hospital JA, Cequier A. The MGuard coronary stent: safety, efficacy, and clinical utility. Vasc Health Risk Manag. 2015;11:533–9.

    PubMed  PubMed Central  Google Scholar 

  42. Grube E, Hauptmann KE, Muller R, Uriel N, Kaluski E. Coronary stenting with MGuard: extended follow-up of first human trial. Cardiovasc Revasc Med. 2011;12(3):138–46.

    Article  PubMed  Google Scholar 

  43. Karatasakis A, Akhtar YN, Brilakis ES. Distal coronary perforation in patients with prior coronary artery bypass graft surgery: the importance of early treatment. Cardiovasc Revasc Med. 2016;17(6):412–7.

    Article  PubMed  Google Scholar 

  44. Brilakis ES, O’Donnell CI, Penny W, Armstrong EJ, Tsai T, Maddox TM, Plomondon ME, Banerjee S, Rao SV, Garcia S, Nallamothu B, Shunk KA, Mavromatis K, Grunwald GK, Bhatt DL. Percutaneous coronary intervention in native coronary arteries versus bypass grafts in patients with prior coronary artery bypass graft surgery: insights from the veterans affairs clinical assessment, reporting, and tracking program. JACC Cardiovasc Interv. 2016;9(9):884–93.

    Article  PubMed  Google Scholar 

  45. Brilakis ES, Rao SV, Banerjee S, Goldman S, Shunk KA, Holmes DR Jr, Honeycutt E, Roe MT. Percutaneous coronary intervention in native arteries versus bypass grafts in prior coronary artery bypass grafting patients a report from the national cardiovascular data registry. JACC Cardiovasc Interv. 2011;4(8):844–50.

    Article  PubMed  Google Scholar 

  46. Michael TT, Karmpaliotis D, Brilakis ES, Fuh E, Patel VG, Mogabgab O, Alomar M, Kirkland BL, Lembo N, Kalynych A, Carlson H, Banerjee S, Lombardi W, Kandzari DE. Procedural outcomes of revascularization of chronic total occlusion of native coronary arteries (from a Multicenter United States Registry). Am J Cardiol. 2013;112(4):488–92.

    Article  PubMed  Google Scholar 

  47. Brilakis ES, Banerjee S, Lombardi WL. Retrograde recanalization of native coronary artery chronic occlusions via acutely occluded vein grafts. Catheter Cardiovasc Interv. 2010;75(1):109–13.

    PubMed  Google Scholar 

  48. Varghese I, Samuel J, Banerjee S, Brilakis ES. Comparison of percutaneous coronary intervention in native coronary arteries vs. bypass grafts in patients with prior coronary artery bypass graft surgery. Cardiovasc Revasc Med. 2009;10(2):103–9.

    Article  PubMed  Google Scholar 

  49. Sdringola S, Assali A, Ghani M, Yepes A, Rosales O, Schroth GW, Fujise K, Anderson HV, Smalling RW. Adenosine use during aortocoronary vein graft interventions reverses but does not prevent the slow-no reflow phenomenon. Catheter Cardiovasc Interv. 2000;51(4):394–9.

    Article  CAS  PubMed  Google Scholar 

  50. Zoghbi GJ, Goyal M, Hage F, Meyers RP, Papapietro SE, Brott BC, Misra VK, Iskandrian AE, Hillegass WB. Pretreatment with nitroprusside for microcirculatory protection in saphenous vein graft interventions. J Invasive Cardiol. 2009;21(2):34–9.

    PubMed  Google Scholar 

  51. Fischell TA, Subraya RG, Ashraf K, Perry B, Haller S. «Pharmacologic» distal protection using prophylactic, intragraft nicardipine to prevent no-reflow and non-Q-wave myocardial infarction during elective saphenous vein graft intervention. J Invasive Cardiol. 2007;19(2):58–62.

    PubMed  Google Scholar 

  52. Michaels AD, Appleby M, Otten MH, Dauterman K, Ports TA, Chou TM, Gibson CM. Pretreatment with intragraft verapamil prior to percutaneous coronary intervention of saphenous vein graft lesions: results of the randomized, controlled vasodilator prevention on no-reflow (VAPOR) trial. J Invasive Cardiol. 2002;14(6):299–302.

    PubMed  Google Scholar 

  53. Roffi M, Mukherjee D, Chew DP, Bhatt DL, Cho L, Robbins MA, Ziada KM, Brennan DM, Ellis SG, Topol EJ. Lack of benefit from intravenous platelet glycoprotein IIb/IIIa receptor inhibition as adjunctive treatment for percutaneous interventions of aortocoronary bypass grafts: a pooled analysis of five randomized clinical trials. Circulation. 2002;106(24):3063–7.

    Article  PubMed  Google Scholar 

  54. Coolong A, Baim DS, Kuntz RE, O'Malley AJ, Marulkar S, Cutlip DE, Popma JJ, Mauri L. Saphenous vein graft stenting and major adverse cardiac events: a predictive model derived from a pooled analysis of 3958 patients. Circulation. 2008;117(6):790–7.

    Article  PubMed  Google Scholar 

  55. Sachdeva A, Bavisetty S, Beckham G, Shen AY, Aharonian V, Mansukhani P, Stone GW, Leon M, Moses J, Moore N, Hyett R, Contreras R, Brar SS. Discontinuation of long-term clopidogrel therapy is associated with death and myocardial infarction after saphenous vein graft percutaneous coronary intervention. J Am Coll Cardiol. 2012;60(23):2357–63.

    Article  CAS  PubMed  Google Scholar 

  56. Yeh RW, Secemsky EA, Kereiakes DJ, Normand SL, Gershlick AH, Cohen DJ, Spertus JA, Steg PG, Cutlip DE, Rinaldi MJ, Camenzind E, Wijns W, Apruzzese PK, Song Y, Massaro JM, Mauri L, Investigators DS. Development and validation of a prediction rule for benefit and harm of dual antiplatelet therapy beyond 1 year after percutaneous coronary intervention. JAMA. 2016;315(16):1735–49.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Abdel-Karim AR, Banerjee S, Brilakis ES. Percutaneous intervention of acutely occluded saphenous vein grafts: contemporary techniques and outcomes. J Invasive Cardiol. 2010;22(6):253–7.

    PubMed  Google Scholar 

  58. Ebersole D, Dahm JB, Das T, Madyoon H, Vora K, Baker J, Hilton D, Alderman E, Topaz O. Excimer laser revascularization of saphenous vein grafts in acute myocardial infarction. J Invasive Cardiol. 2004;16(4):177–80.

    PubMed  Google Scholar 

  59. Fiorina C, Meliga E, Chizzola G, Curello S, Tayeh O, Vizzardi E, Dei Cas L, Ettori F. Early experience with a new approach for percutaneous intervention of totally occluded saphenous vein graft: is the flow the best thrombolytic? EuroIntervention. 2010;6(4):461–6.

    Article  PubMed  Google Scholar 

  60. Teramoto T, Tsuchikane E, Matsuo H, Suzuki Y, Ito T, Ito T, Habara M, Nasu K, Kimura M, Kinoshita Y, Terashima M, Asakura Y, Matsubara T, Suzuki T. Initial success rate of percutaneous coronary intervention for chronic total occlusion in a native coronary artery is decreased in patients who underwent previous coronary artery bypass graft surgery. JACC Cardiovasc Interv. 2014;7(1):39–46.

    Article  PubMed  Google Scholar 

  61. Al-Lamee R, Ielasi A, Latib A, Godino C, Ferraro M, Arioli F, Mussardo M, Piraino D, Figini F, Carlino M, Montorfano M, Chieffo A, Colombo A. Clinical and angiographic outcomes after percutaneous recanalization of chronic total saphenous vein graft occlusion using modern techniques. Am J Cardiol. 2010;106(12):1721–7.

    Article  PubMed  Google Scholar 

  62. Jim MH, Ho HH, Ko RL, Siu CW, Yiu KH, Lau CP, Chow WH. Paclitaxel-eluting stents for chronically occluded saphenous vein grafts (EOS) study. J Interv Cardiol. 2010;23(1):40–5.

    Article  PubMed  Google Scholar 

  63. Nguyen-Trong PK, Alaswad K, Karmpaliotis D, Lombardi W, Grantham JA, Lembo N, Kandzari D, Karatasakis A, Karacsonyi J, Danek BA, Rangan BV, Roesle M, Ayers CR, Thompson CA, Banerjee S, Brilakis ES. Use of saphenous vein bypass grafts for retrograde recanalization of coronary chronic total occlusions: insights from a multicenter registry. J Invasive Cardiol. 2016;28(6):218–24.

    PubMed  Google Scholar 

  64. Mhatre A, Uretsky BF, Sachdeva R. Substrate for complications. J Invasive Cardiol. 2012;24(7):E153–6.

    PubMed  Google Scholar 

  65. Lichtenwalter C, de Lemos JA, Roesle M, Obel O, Holper EM, Haagen D, Saeed B, Iturbe JM, Shunk K, Bissett JK, Sachdeva R, Voudris VV, Karyofillis P, Kar B, Rossen J, Fasseas P, Berger P, Banerjee S, Brilakis ES. Clinical presentation and angiographic characteristics of saphenous vein graft failure after stenting: insights from the SOS (stenting of saphenous vein grafts) trial. JACC Cardiovasc Interv. 2009;2(9):855–60.

    Article  PubMed  Google Scholar 

  66. Ashby DT, Dangas G, Aymong EA, Iakovou I, Kuepper F, Mehran R, Stone GW, Leon MB, Moses JW. Effect of percutaneous coronary interventions for in-stent restenosis in degenerated saphenous vein grafts without distal embolic protection. J Am Coll Cardiol. 2003;41(5):749–52.

    Article  PubMed  Google Scholar 

  67. Hong YJ, Jeong MH, Ahn Y, Kang JC, Mintz GS, Kim SW, Lee SY, Kim SY, Pichard AD, Satler LF, Waksman R, Weissman NJ. Impact of lesion location on intravascular ultrasound findings and short-term and five-year long-term clinical outcome after percutaneous coronary intervention for saphenous vein graft lesions. Int J Cardiol. 2013;167(1):29–33.

    Article  PubMed  Google Scholar 

  68. Wood FO, Badhey N, Garcia B, Abdel-karim AR, Maini B, Banerjee S, Brilakis ES. Analysis of saphenous vein graft lesion composition using near-infrared spectroscopy and intravascular ultrasonography with virtual histology. Atherosclerosis. 2010;212(2):528–33.

    Article  CAS  PubMed  Google Scholar 

  69. Brilakis ES, Maniu C, Wahl M, Barsness G. Unstable angina due to stent fracture. J Invasive Cardiol. 2004;16(9):545.

    PubMed  Google Scholar 

  70. Abdel-Karim AR, Da Silva M, Lichtenwalter C, de Lemos JA, Obel O, Addo T, Roesle M, Haagen D, Rangan BV, Makke L, Jeroudi OM, Raghunathan D, Saeed B, Bissett JK, Sachdeva R, Voudris VV, Karyofillis P, Kar B, Rossen J, Fasseas P, Berger P, Banerjee S, Brilakis ES. Prevalence and outcomes of intermediate saphenous vein graft lesions: findings from the stenting of saphenous vein grafts randomized-controlled trial. Int J Cardiol. 2013;168(3):2468–73.

    Article  PubMed  Google Scholar 

  71. Aqel R, Zoghbi GJ, Hage F, Dell'Italia L, Iskandrian AE. Hemodynamic evaluation of coronary artery bypass graft lesions using fractional flow reserve. Catheter Cardiovasc Interv. 2008;72(4):479–85.

    Article  PubMed  Google Scholar 

  72. Rodes-Cabau J, Bertrand OF, Larose E, Dery J-P, Rinfret S, Bagur R, Proulx G, Nguyen CM, Cote M, Landcop M-C, Boudreault J-R, Rouleau J, Roy L, Gleeton O, Barbeau G, Noel B, Courtis J, Dagenais GR, Despres J-P, DeLarochelliere R. Comparison of plaque sealing with paclitaxel-eluting stents versus medical therapy for the treatment of moderate nonsignificant saphenous vein graft lesions. The moderate VEin graft LEsion stenting with the Taxus stent and intravascular ultrasound (VELETI) pilot trial. Circulation. 2009;120:1978–86.

    Article  PubMed  Google Scholar 

  73. Rodes-Cabau J, Bertrand OF, Larose E, Dery JP, Rinfret S, Urena M, Jerez M, Nombela-Franco L, Ribeiro HB, Allende R, Proulx G, Nguyen CM, Boudreault JR, Rouleau J, Roy L, Gleeton O, Barbeau G, Noel B, Cote M, Despres JP, Dagenais GR, DeLarochelliere R. Five-year follow-up of the plaque sealing with paclitaxel-eluting stents vs medical therapy for the treatment of intermediate nonobstructive saphenous vein graft lesions (VELETI) trial. Can J Cardiol. 2014;30(1):138–45.

    Article  PubMed  Google Scholar 

  74. Rodes-Cabau J, Jolly SS, Cairns J, Mansour S, L’Allier PL, Teefy PJ, Graham JJ, Le May MR, Cantor WJ, Wood D, Balasubramanian K, DeLarochelliere R, Dzavik V, VELETI II Investigators. Sealing intermediate nonobstructive coronary saphenous vein graft lesions with drug-eluting stents as a new approach to reducing cardiac events: a randomized controlled trial. Circ Cardiovasc Interv. 2016;9(11):e004336.

    Article  CAS  PubMed  Google Scholar 

Download references

Disclosures

Dr. Banerjee: Research grants from Gilead and the Medicines Company; consultant/speaker honoraria from Covidien and Medtronic; ownership in MDCARE Global (spouse); intellectual property in HygeiaTel.

Dr. Brilakis: Consulting/speaker honoraria from Abbott Vascular, Asahi, Cardinal Health, Elsevier, GE Healthcare and St Jude Medical; research support from Boston Scientific and InfraRedx; spouse is employee of Medtronic.

The remaining authors have no conflicts of interest to disclose.

Author information

Authors and Affiliations

  1. VA North Texas Health Care System and UT Southwestern Medical Center, Dallas, TX, USA

    Judit Karacsonyi MD, Subhash Banerjee MD & Emmanouil S. Brilakis MD, PhD

  2. Division of Invasive Cardiology, Second Department of Internal Medicine and Cardiology Center, University of Szeged, Szeged, Hungary

    Judit Karacsonyi MD & Imre Ungi MD

  3. Minneapolis Heart Institute, 920 E 28th Street #300, Minneapolis, 55407, MN, USA

    Anil Poulose MD, Ivan Chavez MD, Yale Wang MD & Emmanouil S. Brilakis MD, PhD

Authors
  1. Judit Karacsonyi MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anil Poulose MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ivan Chavez MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yale Wang MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Imre Ungi MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Subhash Banerjee MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Emmanouil S. Brilakis MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Emmanouil S. Brilakis MD, PhD .

Editor information

Editors and Affiliations

  1. Middle German Heart Center and Health Care Center Bitterfeld-Wolfen, gGmbH, Bitterfeld-Wolfen, Germany

    Peter Lanzer

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Karacsonyi, J. et al. (2018). Coronary Venous Bypass Lesions. In: Lanzer, P. (eds) Textbook of Catheter-Based Cardiovascular Interventions. Springer, Cham. https://doi.org/10.1007/978-3-319-55994-0_50

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-55994-0_50

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-55993-3

  • Online ISBN: 978-3-319-55994-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation